Abound Financial’s DexCom DXCM Stock Holding History

Abound Financial’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.2K	Hold	256	–	–	0.01%	192
2026 Q1	$16.1K	Hold	256	–	–	0.01%	187
2025 Q4	$17K	Buy	+256	New	+$16.6K	0.01%	189

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Abound Financial's DXCM Position: Q2 2026 in Review

Abound Financial held its DexCom (DXCM) position steady in Q2 2026 at 256 shares worth $17.2K. The position accounts for 0.01% of the portfolio, ranked #192.

Abound Financial first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Abound Financial held 256 shares of DexCom worth $17.2K as of Q2 2026.
Abound Financial left its DexCom share count unchanged in Q2 2026.
DexCom made up 0.01% of Abound Financial's portfolio in Q2 2026, its #192 holding.
Abound Financial first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Abound Financial's 13F filing for Q2 2026, filed 14 Aug 2026.